title: Experimental (antiestrogen-mediated) reduction in egg size negatively affects offspring growth and survival.
abstract: The relationship between egg size and offspring phenotype is critical to our understanding of the selective pressures acting on the key reproductive life-history traits of egg size and number. Yet there is surprisingly little empirical evidence to support a strong, positive relationship between egg size and offspring quality (i.e., offspring growth, condition, and survival) in birds, in part because of confounding effects of parental quality and the lack of experimental techniques for directly manipulating avian egg size independently of maternal condition. Previously, we showed that treatment of laying female zebra finches (Taeniopygia guttata) with the antiestrogen tamoxifen can decrease egg size by ca. 8% but that this reduction in egg size had few effects on offspring mass and size at fledging. Here, we extend the use of this technique to induce larger decreases in egg size (up to 50% in individual females) and show that a reduction in egg size of ca. 18% is associated with decreased embryo viability, increased hatchling mortality, and lower posthatching offspring survival. Furthermore, we show that although hatchlings from eggs reduced in size by ca. 9% can survive to fledging, these chicks show slower initial growth during the linear growth phase (5-10 d of age), fledge at lower masses than chicks from control eggs, and show postfledging compensatory growth. Our results provide empirical support for significant effects of egg size on offspring quality and further suggest that among individual females there is a minimum egg size required to maintain embryo viability and offspring quality.
authors: Department of Biological Sciences, Simon Fraser University, 8888 University Drive, Burnaby, British Columbia V5A 1S6, Canada. ewagner@sfu.ca
authors: Emily C
authors: EC
authors: Wagner
authors: Tony D
authors: TD
authors: Williams
mesh_terms: D000818:Animals; D048429:Cell Size / Q000187:drug effects; D004965:Estrogen Antagonists / Q000494:pharmacology*; D005260:Female; D046369:Finches / Q000254:growth & development*; D010063:Ovum / Q000166:cytology* / Q000187:drug effects*; D015996:Survival Rate; D013629:Tamoxifen / Q000494:pharmacology*
chemical_list: D004965:Estrogen Antagonists; D013629:Tamoxifen